3rd International Protein Phosphorylation Drug Discovery World Summit

Venue: Marriott La Jolla

Location: San Diego, California, United States

Event Date/Time: Feb 28, 2005 End Date/Time: Mar 01, 2005
Report as Spam


Our annual conference on protein phosphorylation in drug discovery is the best-attended conference for industrial kinase and phosphatase researchers to get the latest updates on cutting-edge science and technology advances in the field. Over 1,000 scientists and business development directors have attended this conference series since its inception in 2001, providing robust networking opportunities and a forum to discuss the latest hurdles and potential solutions for this very exciting field.

Featured presentations this year include:

“Protein Kinases and Disease in the Postgenomic Era”
Tony Hunter, Ph.D.
Professor, Molecular and Cell Biology Laboratory
The Salk Institute

“Protein Kinase Inhibitors – Lessons Learned”
Doriano Fabbro, Ph.D.
Head in Signalling Pathways
Novartis Pharma AG

New for 2005!

This year’s program will spotlight an interactive panel discussion where leaders in field will discuss varies topics such as: meaningful selectivity, drugability of kinases, relevance of animal models to clinical experience, pitfalls for failures in kinase clinical programs and more. Panel participants include: Doriano Fabbro (Novartis Pharma AG), Tony Hunter (The Salk Institute), Blaine Knight (GlaxoSmithKline), Steven Pelech (Kinexus Bioinformatics) and discussion leader, Peter Blume-Jensen (Serono Reproductive Biology Institute).
In two days, you’ll be quickly updated on the state-of-the-art of protein kinase and phosphatase-based therapeutics, and come away with an overall perspective that shall enable you to apply what you learn to your own in-house efforts, select new avenues for investigation, or prospect new partners for licensing and other collaborations.

We look forward to welcoming you in San Diego!


4240 La Jolla Village Drive
San Diego
United States